
A mixed cell-culture and mouse study found that Ahiflower oil, a plant-based omega-3 source, reduced markers of endothelial inflammation, blood lipids, and platelet clotting activity at levels comparable to fish oil.
Pronova BioPharma owns the patent to omega-3 cardiovascular drug Lovaza.
The extended deadline is for BASF to acquire any outstanding shares of Pronova. BASF says it so far has received acceptances for approximately 67.2% of shares.


